feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Shingles Vaccine Linked to Healthier Aging

Shingles Vaccine Linked to Healthier Aging

21 Jan

•

Summary

  • Shingles vaccination is associated with reduced biological aging signs.
  • Vaccinated individuals showed less inflammation and slower aging.
  • The vaccine may support healthier aging by reducing inflammation.
Shingles Vaccine Linked to Healthier Aging

A recent study involving over 3,800 individuals indicates that the shingles vaccination may contribute to healthier aging. The research observed that vaccinated participants showed diminished signs of biological aging and inflammation.

These findings suggest that the vaccine could potentially slow age-related decline by reducing background inflammation. This mechanism might be linked to preventing the reactivation of the virus that causes shingles.

The study measured seven aspects of biological aging, including inflammation, immune response, and epigenetic aging. Participants who received the shingles jab demonstrated significantly lower inflammation levels and slower epigenetic and transcriptomic aging.

trending

Army vehicle plunges in Doda

trending

Nurses infected with Nipah virus

trending

IIFL shares plunge after tax

trending

Delhi weather: Yellow alert issued

trending

Punjab rain yellow alert

trending

Sarfaraz Khan assets uncovered

trending

FSSAI enforcement has limited impact

trending

Gold, silver prices fall

trending

Volkswagen shares top DAX

These results align with emerging evidence connecting adult vaccines, such as those for shingles and influenza, with reduced risks of dementia and neurodegenerative disorders. The research highlights the potential for vaccines to modulate biological systems beyond merely preventing infection, thereby promoting resilience and supporting healthy aging strategies.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The shingles vaccine may help reduce biological aging and inflammation, contributing to overall healthier aging.
The vaccine may help reduce background inflammation, which is a known contributor to various age-related conditions.
The shingles vaccine is available on the NHS for adults turning 65 and those aged between 70 and 79 years old.

Read more news on

Healthside-arrow

You may also like

Flu Deaths Climb: 32 Children Lost, Most Unvaccinated

20 Jan • 30 reads

article image

Winter Rash? Shingles Cases Surge 50%

12 Jan • 6 reads

article image

Vaccines May Slash Dementia Risk, Study Shows

7 Jan • 124 reads

article image

COVID Booster May Slightly Raise Shingles Risk

19 Dec, 2025 • 174 reads

article image

B.C. ERs Overwhelmed: Parents Urged to Vaccinate Amidst Flu Surge

17 Dec, 2025 • 185 reads